MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 94 filers reported holding MENLO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,304,000 | -38.8% | 3,643,824 | -5.2% | 0.45% | -51.6% |
| Q1 2020 | $10,301,000 | -57.1% | 3,843,824 | -4.2% | 0.93% | -58.6% |
| Q2 2019 | $24,027,000 | -23.7% | 4,011,236 | 0.0% | 2.25% | -28.3% |
| Q1 2019 | $31,488,000 | +90.5% | 4,011,236 | 0.0% | 3.14% | +48.8% |
| Q4 2018 | $16,526,000 | -58.2% | 4,011,236 | 0.0% | 2.11% | -47.0% |
| Q3 2018 | $39,511,000 | +21.3% | 4,011,236 | 0.0% | 3.98% | -5.1% |
| Q2 2018 | $32,571,000 | -78.4% | 4,011,236 | 0.0% | 4.20% | -80.3% |
| Q1 2018 | $150,742,000 | – | 4,011,236 | – | 21.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 4,359,030 | $7,541,000 | 8.27% |
| Healthcare Value Capital, LLC | 1,700,000 | $2,941,000 | 7.51% |
| 683 Capital Management, LLC | 5,550,208 | $9,602,000 | 0.77% |
| Perceptive Advisors | 22,876,410 | $39,576,000 | 0.64% |
| Vivo Capital, LLC | 3,643,824 | $6,304,000 | 0.45% |
| Monashee Investment Management LLC | 1,005,000 | $1,739,000 | 0.26% |
| MYDA Advisors LLC | 93,300 | $161,000 | 0.10% |
| Sofinnova Investments, Inc. | 725,571 | $1,256,000 | 0.08% |
| CAAS CAPITAL MANAGEMENT LP | 1,185,501 | $2,051,000 | 0.07% |
| Grace Capital | 36,012 | $62,000 | 0.05% |